Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism.
about
Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the ChlamydiaceaeA chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actinBioinformatics analysis of the locus for enterocyte effacement provides novel insights into type-III secretionA path forward for the chlamydial virulence factor CPAFBiochemical and Structural Insights into Microtubule Perturbation by CopN from Chlamydia pneumoniaeType Three Secretion System in Attaching and Effacing PathogensBioinformatic and biochemical evidence for the identification of the type III secretion system needle protein of Chlamydia trachomatisChlamydia pneumoniae effector chlamydial outer protein N sequesters fructose bisphosphate aldolase A, providing a benefit to bacterial growthMechanisms of host cell exit by the intracellular bacterium Chlamydia.Genomic approach for analysis of surface proteins in Chlamydia pneumoniaeComparative proteome analysis of Chlamydia trachomatis serovar A, D and L2.Characterization of a secreted Chlamydia protease.Exploration of chlamydial type III secretion system reconstitution in Escherichia coli.Characterization of hypothetical proteins Cpn0146, 0147, 0284 & 0285 that are predicted to be in the Chlamydia pneumoniae inclusion membrane.Human GCIP interacts with CT847, a novel Chlamydia trachomatis type III secretion substrate, and is degraded in a tissue-culture infection model.Spatial constraints within the chlamydial host cell inclusion predict interrupted development and persistenceChlamydophila felis CF0218 is a novel TMH family protein with potential as a diagnostic antigen for diagnosis of C. felis infection.Small molecule inhibitors of the Yersinia type III secretion system impair the development of Chlamydia after entry into host cellsAccurate prediction of secreted substrates and identification of a conserved putative secretion signal for type III secretion systemsThe Chlamydia type III secretion system C-ring engages a chaperone-effector protein complex.Interactions between flagellar and type III secretion proteins in Chlamydia pneumoniae.The Salmonella enterica serovar typhimurium-encoded type III secretion systems can translocate Chlamydia trachomatis proteins into the cytosol of host cells.The Chlamydia trachomatis type III secretion substrates CT142, CT143, and CT144 are secreted into the lumen of the inclusion.Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severityEnhancer-binding proteins HrpR and HrpS interact to regulate hrp-encoded type III protein secretion in Pseudomonas syringae strains.Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates.Analysis of the expression, secretion and translocation of the Salmonella enterica type III secretion system effector SteAInhibition of apoptosis by gamma interferon in cells and mice infected with Chlamydia muridarum (the mouse pneumonitis strain of Chlamydia trachomatis).Chlamydia trachomatis induces remodeling of the actin cytoskeleton during attachment and entry into HeLa cells.Inhibition of fusion of Chlamydia trachomatis inclusions at 32 degrees C correlates with restricted export of IncA.The chlamydial developmental cycle.Identification of novel type III secretion chaperone-substrate complexes of Chlamydia trachomatis.Secretion of the chlamydial virulence factor CPAF requires the Sec-dependent pathwayRecombinant Cpn 0810 stimulates proinflammatory cytokine expression and apoptosis in human monocytes.Biophysical characterization of Chlamydia trachomatis CT584 supports its potential role as a type III secretion needle tip protein.Temporal expression of type III secretion genes of Chlamydia pneumoniae.The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis.A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.Chlamydia trachomatis secretion of proteases for manipulating host signaling pathways.A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis.
P2860
Q22065992-A44EDB40-C5CE-4BC9-987E-307FFB2C45BEQ24564460-3C36F94E-9390-421B-B213-E4416B8FB861Q24791468-75E57339-3322-42EB-A9EC-5F30D0CE74CEQ27014318-65662227-4909-4A5B-A899-A25DAA01E89BQ27684803-BC3B3D02-4634-40A7-BB2A-EAC9946C09E1Q28074332-95B7EFC1-1718-4C80-ABCA-9F4C535D22A4Q28484742-DD9740D7-44A5-4547-9D95-C1A61AC5BDDFQ30389751-12E1DF74-87CA-439B-957C-A51ABAC0B5BEQ30480273-E53B2FF9-6E7B-450E-839D-2E81ADF75456Q31032708-86B00B76-E5A9-43F2-AECE-5DF48DD6E9ADQ31038366-2214AF04-31C9-460C-A6A9-D42FF0BA4B43Q31095299-24881735-7A75-4F69-AA92-4231BDD8F944Q31109123-D075294B-9416-47D1-8B21-51F9434D3586Q33284727-285EA3A9-C383-4674-8751-32F44BC16904Q33285974-DB241B2B-6196-404C-95D1-7029F7E643C6Q33313651-4B844BFE-24DD-4C05-8CB7-7A9CBDB73200Q33366326-24F18190-879C-45B8-A867-722090D6F817Q33433231-FE078B5A-4A11-4647-89AD-E5F25F4F6121Q33434470-CE2AD82A-ABE0-486E-B007-E5DDCCC200A9Q33502747-0E82F2F4-C5BB-40B5-979B-E0DDCEAB47B1Q33526048-658586EB-ED74-40C6-8CF1-D50F1035563CQ33795576-26A04715-77EF-41CE-8F80-DA8A2329131CQ33806902-796727CC-6E77-4DF2-AE6D-4AE067347FB6Q33885417-52E12232-317D-4C8C-90D4-D587A63C1E69Q33996908-0730B4C1-244C-4DE0-94DF-874C38C97974Q34048332-8B3D17FA-CAFD-48F9-9257-E403D746BB97Q34064840-45020CF1-E285-4F0A-845A-593005A9B798Q34121130-487DA078-3790-4FFC-9EEA-437E71BC3B23Q34124851-DA809405-2DB6-4702-8716-07F714E08059Q34125191-036B1A01-B738-47DD-8849-76714C88C7D3Q34436827-5B88886D-4F03-4BC6-B264-68A3D17BEE5AQ34595020-8DB38079-695F-467A-B4B8-BAA32F5CB3E0Q34747052-00C8FE09-DC29-4B3B-884C-F9F1DBD6294AQ34795467-EDCD42FC-997A-4F2C-956A-EAB81D54564AQ34851073-E6C28922-08C5-4AF9-B613-CC437C0427F5Q34935390-83C478EA-544E-4648-997E-5D43CD51EC03Q34975886-F75A0316-D040-40B2-BA52-FBC9CF255D53Q34980175-F7917C91-789B-40B1-B58D-54A8256B06F3Q35028580-38A8AA40-AFA7-4C25-B992-3AD1254723E1Q35029284-7037E58A-2374-488A-89FF-4B430ED4B738
P2860
Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence for the secretion of ...... type III secretion mechanism.
@en
Evidence for the secretion of ...... type III secretion mechanism.
@nl
type
label
Evidence for the secretion of ...... type III secretion mechanism.
@en
Evidence for the secretion of ...... type III secretion mechanism.
@nl
prefLabel
Evidence for the secretion of ...... type III secretion mechanism.
@en
Evidence for the secretion of ...... type III secretion mechanism.
@nl
P2860
P1476
Evidence for the secretion of ...... a type III secretion mechanism
@en
P2093
K A Fields
P2860
P304
P356
10.1046/J.1365-2958.2000.02212.X
P407
P577
2000-12-01T00:00:00Z